A2 Biotherapeutics
PrivateLast Round
Grant
May 6, 2025
Total Funding Raised
$270.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
A2 Biotherapeutics is a biotechnology company that develops logic-gated cell therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
A2 Biotherapeutics Comparables
Compare A2 Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ArsenalBio | 89% | |
| Eureka Therapeutics | 82% | |
| Link Cell Therapies | 82% | |
A2 Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 6, 2025 | ||||
| Series C | Jan 9, 2025 | ||||
| Series B Extension | Dec 19, 2022 | ||||
| Series B | Oct 6, 2020 | ||||
| Series A Extension | Nov 5, 2019 |
Key People
Founding team and executive leadership
A2 Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series A Extension, Series C |
| Perceptive Advisors | Series C |
| Vida Ventures | Series B, Series C, Series A Extension |
| Aisling Capital | Series C |
| Casdin Capital | Series B |
| Nextech Invest | Series B, Series A Extension |
| UC Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Three abstracts accepted for presentation at the 2026 ASCO Annual Meeting.
- Oct 3, 2025
Four abstracts accepted for the Society for Immunotherapy of Cancer meeting.
A2 Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about A2 Biotherapeutics's valuation, stock price, and market status.